Search research articles
Contact Us
Filters
Showing results (651-660 of 839) with videos related to
Page
of 84
Sort By:
Horticulture Research
|
January 18, 2022
microRNA172 targets APETALA2 to regulate flavonoid biosynthesis in apple (Malus domestica)
Tiyu Ding, Sumathi Tomes, Andrew P Gleave, et al.
Pathology Oncology Research : POR
|
April 7, 2018
A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores
Sami-Ramzi Leyh-Bannurah, Dominique Trudel, Mathieu Latour, et al.
EMBO Molecular Medicine
|
September 28, 2019
The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer
Yuqian Yan, Jian Ma, Dejie Wang, et al.
Cell Genomics
|
June 11, 2025
CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of REST
Liangliang Liu, Itzel Astiazarán Rascón, Dong Lin, et al.
European Urology
|
March 17, 2018
Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer
Jun Hao, Xinpei Ci, Hui Xue, et al.
Plos One
|
September 25, 2015
Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye
Aditi Bauskar, Wendy J Mack, Jerome Mauris, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
November 29, 2024
High throughput application of the NanoBiT Biochemical Assay for the discovery of selective inhibitors of the interaction of PI3K-p110α with KRAS
Mohamed Ismail, Gareth Davies, Graham Sproat, et al.
Cancer Discovery
|
January 26, 2018
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Matti Annala, Gillian Vandekerkhove, Daniel Khalaf, et al.
European Urology
|
February 14, 2018
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study
James T Kearns, Anna V Faino, Lisa F Newcomb, et al.
European Urology
|
March 31, 2015
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator
Donna P Ankerst, Jing Xia, Ian M Thompson, et al.
Page
of 84
Search research articles
Search
Showing results (651-660 of 839) with videos related to
Sort By:
Page
of 84
Horticulture Research
|
January 18, 2022
microRNA172 targets APETALA2 to regulate flavonoid biosynthesis in apple (Malus domestica)
Tiyu Ding, Sumathi Tomes, Andrew P Gleave, et al.
Pathology Oncology Research : POR
|
April 7, 2018
A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores
Sami-Ramzi Leyh-Bannurah, Dominique Trudel, Mathieu Latour, et al.
EMBO Molecular Medicine
|
September 28, 2019
The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer
Yuqian Yan, Jian Ma, Dejie Wang, et al.
Cell Genomics
|
June 11, 2025
CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of REST
Liangliang Liu, Itzel Astiazarán Rascón, Dong Lin, et al.
European Urology
|
March 17, 2018
Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer
Jun Hao, Xinpei Ci, Hui Xue, et al.
Plos One
|
September 25, 2015
Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye
Aditi Bauskar, Wendy J Mack, Jerome Mauris, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
November 29, 2024
High throughput application of the NanoBiT Biochemical Assay for the discovery of selective inhibitors of the interaction of PI3K-p110α with KRAS
Mohamed Ismail, Gareth Davies, Graham Sproat, et al.
Cancer Discovery
|
January 26, 2018
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Matti Annala, Gillian Vandekerkhove, Daniel Khalaf, et al.
European Urology
|
February 14, 2018
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study
James T Kearns, Anna V Faino, Lisa F Newcomb, et al.
European Urology
|
March 31, 2015
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator
Donna P Ankerst, Jing Xia, Ian M Thompson, et al.
Page
of 84